Kelowna, BC, Canada – TheNewswire – December 3, 2024 Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) is pleased to announce the signing of a new supply agreement with an Australian-based medicinal cannabis company. The agreement will see Allied supplying Colombian-grown cannabis flower, further expanding its presence in Australia, a key market in Allied’s global strategy.

Allied’s partner has placed an initial purchase order for 50 kilograms of smokeable cannabis flower, with import permits already granted by the Australian regulators and delivery expected in early Q1 2025. This is part of a Master Agreement setting terms for additional sales, with a follow-up order of 200 kilograms anticipated in H1 2025, subject to initial product meeting specifications.

“This agreement supports our commitment to expanding our footprint in Australia”, said Juba Hadid, Allied’s VP of Global Sales. "Streamlined supply chains to trusted partners will be key to our success moving forward.  We look forward to growing our relationship as our partners continues to establish themselves as a leader in Australia’s medical cannabis industry".

This agreement supports Allied’s broader global expansion strategy, which has already seen successful partnerships and shipments announced in Europe and Australia across 2024. Notably, Allied recently announced a successful shipment to its channel partner in Portugal to begin satisfying a United Kingdom based distribution agreement, along with the signing of an exclusive forward purchase agreement worth EUR 15.3 million over 5 years with Canpoland, a Polish distributor, including minimum volume commitments of 1.05 tons of premium Colombian-grown Cannabis flower per annum.

 

About Allied Corp

Allied Corp is a Canadian cannabis supplier with its production center in Colombia. By leveraging Canadian cannabis cultivation expertise and Colombian price advantages, Allied offers consistent supply of premium cannabis product at scale and at attractive prices, meeting international high-quality standards.

Investor Relations :

ir@allied.health

1-877-255-4337

Disclaimer and Forward-Looking Statements:

 

Neither the OTCQB nor any regulatory authority assumes responsibility for the accuracy or adequacy of this release.

This press release includes certain statements that may be deemed "forward-looking statements" under U.S. and Canadian securities laws. Forward-looking statements relate to Allied Corp.’s anticipated developments, strategic objectives, performance, and market opportunities. These include, but are not limited to, statements regarding Allied’s growth in Colombia, Kelowna, Nevada, and other key locations; intellectual property filings; joint development and manufacturing initiatives; and planned product introductions.

Forward-looking statements can often be identified by terms such as "anticipates," "believes," "expects," "intends," "plans," "will," "may," and similar expressions. These statements are based on current assumptions, projections, and management’s experience, but are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Notable risks include, but are not limited to, regulatory risks associated with the cannabis industry and market changes ; risks related to competition within the cannabis and medical industries; risks releated to potential operational and logistical challenges; risks related to market demand; risks related to economic conditions impacting growth and profitability; risks related to potential delays or adverse changes in project locations or expansion plans; as well as any other risk that may be further described in and the risk factors discussed in Allied’s filings with the SEC, available at www.sec.gov.

Though Allied endeavors to identify important factors that may impact actual outcomes, other unknown factors may also cause results to vary. The forward-looking statements contained in this news release are made as of the date of this news release. Except as required by law, the Company disclaims any intention and assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable securities law. Additionally, the Company undertakes no obligation to comment on the expectations of, or statements made, by third parties in respect of the matters discussed above.